There’s a promising new drug for people living with amyotrophic lateral sclerosis (ALS). Recently approved by the FDA, Todd Legg participated in an experimental trial for the new drug at Penn Medicine.
On Tuesday, the FDA granted accelerated approval to the drug, tofersen, meaning others with his type of mutation will be able to get the treatment, too if insurers agree to pay.
Todd Legg started to have trouble breathing in December 2019. Around the same time, he noticed that his hands and arms cramped up when washing dishes at home in Brackney,